Paper17513327
IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
Coppo R and 7 others. J Am Soc Nephrol, 2007. Cited by 191 papers, by iCite.
Cite this record
ConductScience Library. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. Papers, record 17513327. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17513327
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin-Converting Enzyme Inhibitors | Major topic |
| Benzazepines | Major topic |
| Glomerulonephritis, IGA | Major topic |
| Proteinuria | Major topic |
| Adolescent | |
| Adult | |
| Child | |
| Disease Progression | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Placebos | |
| Predictive Value of Tests | |
| Prognosis | |
| Proportional Hazards Models | |
| Risk Factors | |
| Severity of Illness Index | |
| Treatment Outcome |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 17494880 | Is proteinuria reduction by angiotensin-converting enzyme inhibition enough to prove its role in renal protection in IgA nephropathy? | https://conductscience.org/library/papers/17494880 | PubMed |
| Comment in | 17848928 | Is angiotensin-converting-enzyme inhibition renoprotective in young patients with IgA nephropathy? | https://conductscience.org/library/papers/17848928 | PubMed |
Cited by109
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 191 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953388 | Treatment and practical considerations of IgA nephropathy. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42953388 | PubMed |
| 42483537 | Management of IgA nephropathy and the expanding role of immunomodulation. | Kidney Int Suppl (2011) | 2026 | https://conductscience.org/library/papers/42483537 | PubMed |
| 42379652 | Are RAS inhibitors necessary during intensive immunosuppression for lupus nephritis? Real-world evidence from the STAR cohort. | Lupus Sci Med | 2026 | https://conductscience.org/library/papers/42379652 | PubMed |
| 41807808 | Global research trends and hotspots in targeted therapy for IgA nephropathy: a bibliometric and visualization analysis (1999-2025). | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41807808 | PubMed |
| 41767692 | Open-label Randomized Controlled Trial of Controlled-release Formulation Budesonide in Indian Proteinuric IgA Nephropathy Patients. | Kidney Med | 2026 | https://conductscience.org/library/papers/41767692 | PubMed |
| 41746490 | Recent trends in dialysis initiation in Japan: a region‑specific descriptive analysis using Hokkaido as an example. | Clin Exp Nephrol | 2026 | https://conductscience.org/library/papers/41746490 | PubMed |
| 41704425 | Microscopic hematuria in IgA nephropathy: a biomarker of disease activity. | Clin Kidney J | 2026 | https://conductscience.org/library/papers/41704425 | PubMed |
| 41502882 | Optimal drug treatment for children with IgA vasculitis nephritis: a systematic review and network meta-analysis. | Transl Pediatr | 2025 | https://conductscience.org/library/papers/41502882 | PubMed |
| 40869540 | Bradykinin-Mediated Angioedema Induced by Drugs. | J Clin Med | 2025 | https://conductscience.org/library/papers/40869540 | PubMed |
| 40606442 | Efficacy and safety of agents for IgA nephropathy: a network meta-analysis of randomized controlled trials. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40606442 | PubMed |
| 40493692 | Clinical study outcomes in IgA nephropathy: A systematic literature review and narrative synthesis. | PLoS One | 2025 | https://conductscience.org/library/papers/40493692 | PubMed |
| 40328660 | Immune cells mediate the effect of plasma lipidomes on IgA nephropathy: a Mendelian randomization study. | Ren Fail | 2025 | https://conductscience.org/library/papers/40328660 | PubMed |
| 39928268 | Drug Development in Pediatric Chronic Kidney Disease: A Review of Promising Treatments, Old Challenges, and New Strategies. | Paediatr Drugs | 2025 | https://conductscience.org/library/papers/39928268 | PubMed |
| 39331079 | IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. | Pediatr Nephrol | 2025 | https://conductscience.org/library/papers/39331079 | PubMed |
| 39248402 | Prognosis of IgA nephropathy patient with proteinuria remission by supportive therapy: cohort from screening failed Chinese patients in TESTING study. | Ren Fail | 2024 | https://conductscience.org/library/papers/39248402 | PubMed |
| 39188719 | Contemporary review of IgA nephropathy. | Front Immunol | 2024 | https://conductscience.org/library/papers/39188719 | PubMed |
| 38799377 | External Validation of the International IgA Nephropathy Prediction Tool in Older Adult Patients. | Clin Interv Aging | 2024 | https://conductscience.org/library/papers/38799377 | PubMed |
| 38576821 | Immunoglobulin A glomerulonephropathy: A review. | World J Clin Cases | 2024 | https://conductscience.org/library/papers/38576821 | PubMed |
| 38299639 | Non-immunosuppressive treatment for IgA nephropathy. | Cochrane Database Syst Rev | 2024 | https://conductscience.org/library/papers/38299639 | PubMed |
| 37947938 | Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy? | J Nephrol | 2024 | https://conductscience.org/library/papers/37947938 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17513327
GET https://conductscience.org/api/papers/v1/17513327/cited_by?page=2